1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (011) 39 0434 659 524
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Radiotherapy for patients with early-stage glottic carcinoma
Univariate and multivariate analyses in a group of consecutive, unselected patients
Article first published online: 1 JUL 2003
DOI: 10.1002/cncr.11575
Copyright © 2003 American Cancer Society
Additional Information
How to Cite
Franchin, G., Minatel, E., Gobitti, C., Talamini, R., Vaccher, E., Sartor, G., Politi, D., Trovò, M. G. and Barzan, L. (2003), Radiotherapy for patients with early-stage glottic carcinoma. Cancer, 98: 765–772. doi: 10.1002/cncr.11575
Publication History
- Issue published online: 1 AUG 2003
- Article first published online: 1 JUL 2003
- Manuscript Accepted: 12 MAY 2003
- Manuscript Revised: 2 MAY 2003
- Manuscript Received: 11 FEB 2003
- Abstract
- Article
- References
- Cited By
Keywords:
- early glottic laryngeal carcinoma;
- 6-megavolt linear accelerator radiation therapy;
- prognostic factors;
- second primary tumor
Abstract
BACKGROUND
Radiotherapy (RT) has a remarkable success rate in the treatment of patients with glottic carcinoma. The objectives of the current study were to assess the results in a group of consecutive patients with comparable characteristics who were treated with RT (6-megavolt photon linear accelerator) and to determine the prognostic factors that may influence local control in patients with early-stage glottic carcinoma. The impact on local control of tobacco smoking and second primary malignancies also was investigated.
METHODS
Four hundred ten patients with T1–T2 squamous cell carcinoma of the glottis who were treated between 1986 and 2001 were analyzed retrospectively with regard to local control and overall survival. Potential prognostic factors for local control were evaluated with univariate and multivariate models. The impact of technologic advances also was evaluated.
RESULTS
The 5-year and 10-year overall survival rates were 83% and 63.5%, respectively. The overall 10-year local control rate for patients with T1–T2 glottic carcinoma was 89%. The median time to recurrence was 7 months. Univariate analysis showed that tumor category, tumor size, macroscopic appearance of the lesion, RT fraction size, persistent edema, year of RT treatment, unchanged dysphonia, and surgical option all had a significant influence on local control; whereas multivariate analysis showed that only persistent dysphonia and year of RT treatment were significantly associated with increased local control. A 22.2% rate of second primary malignancies was reported: second primary tumors were the major cause of death in the patients studied. Only 2 patients died of laryngeal carcinoma; 304 patients were alive with their disease in complete remission, 1 patient was alive with recurrent laryngeal carcinoma after undergoing salvage surgery, and 103 patients died of either intercurrent disease or a second primary tumor.
CONCLUSIONS
The use of a 6-megavolt photon linear accelerator achieved a high rate of local control in patients with T1–T2 glottic carcinoma. Dysphonia and the year of RT treatment were the most important prognostically significant factors for patient outcome. The occurrence of a second primary tumor was the most frequent cause of death, especially among patients who did not stop smoking after a diagnosis of glottic carcinoma. Cancer 2003;98:765–72. © 2003 American Cancer Society.
DOI 10.1002/cncr.11575